About

Team Leader

Prof. Arben Merkoci (PhD)

ICREA Professor & Group Leader

Phone: +34 618 687 921

Send message

Team Members

Anna Puig

Group Administrator

Phone: +34 937 374 609

Send message

Ruslan Alvarez (PhD)

Postdoc

Phone: +34 937 374 610

Send message

Giulio Rosati (PhD)

Postdoc

Phone: +34 937 373 655

Send message

Celia Fuentes

PhD Student

Phone: +34 937 374 606

Send message

Liming Hu

PhD Student

Phone: +34 937 374 606

Send message

José Alfonso Marrugo

PhD Student

Phone: +34 935 868 016

Send message

Institute Presentation

The Catalan Institute of Nanoscience and Nanotechnology (with its Catalan acronym, ICN2), is a non-profit international research institute located close to Barcelona, Spain. Research at the ICN2 focuses on the physical and chemical properties that arise from the behaviour of matter at the nanoscale. The institute promotes collaboration among scientists from diverse backgrounds to develop basic and applied research, while always seeking out new ways to engage with society and industry. Since 2014, ICN2 has been accredited twice as a Severo Ochoa Centre of Excellence, a programme sponsored by the Spanish Ministry of Science, Innovation and Universities, which aims to recognize the outstanding scientific contributions of Spanish centres, their industrial potential and social impact and their potential for talent attraction. ICN2 is also part of the Barcelona Institute of Science and Technology (BIST), whose mission is to promote cutting-edge research in science and technology within an environment of multidisciplinary scientific excellence. The Nanobioelectronics and Biosensors Group, led by Prof. Arben Merkoçi and formed by a multidisciplinary team at ICN2, carries out research on the integration of nanotechnology methods, tools and materials into low cost, user friendly and efficient sensors and biosensors.

Jointly with CEA and EF CLIF partners, its role within MICROB-PREDICT project will be to develop nanotechnology-based point-of-care (POC) devices for use in clinical units at the bedside, namely personalized assessment of disease stage and prediction of treatment response. Different bio- and nanotechnologic approaches will be employed to couple the optimized POC device to a smartphone-based reading system that will ensure its user-friendly application.